Evidence map›Paper›PMID 28129893›Full record

ArticleEuropean urology2017

A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.

Behfar Ehdaie, Melissa Assel, Nicole Benfante, Deepak Malhotra, Andrew Vickers

Registry-linked trialAbstract read
In one paragraph

Article in European urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04053842 (Multi-modality Prostate Cancer Image Guided Interventions - 5), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04053842 phase2active not recruitingnot on this mapstarted 2021, after this paper: background citation

Multi-modality Prostate Cancer Image Guided Interventions - 5

TypeinterventionalSponsorGlenn BaumanRan2021 to 2025Enrolled45ConditionsProstate Cancer, Prostate Adenocarcinoma, Prostate NeoplasmArmsPET Scan, [18F]PSMA-1007 Injection, Sodium MRI, Multiparametric MRI
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Addressing the problem of overtreatment in breast cancer.Expert review of anticancer therapy · 2022
    Review
  8. Treatment on active surveillance of small renal masses: Progression vs. preference.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  9. Article
  10. Article
  11. Addressing the Dilemma of Contralateral Prophylactic Mastectomy With Behavioral Science.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Behfar EhdaieUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: ehdaieb@mskcc.org.
Melissa AsselHealth Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nicole BenfanteHealth Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Deepak MalhotraNegotiation, Organizations, and Markets Unit, Harvard Business School, Boston, MA, USA.
Andrew VickersHealth Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
SPORE In Prostate CancerP50CA092629 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Yu Chen, MICHAEL J MORRIS · 2001 to 2026
$63.0M
NCI NIH HHS L30 CA199474NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA092629
6 · The paper itself

Abstract

backgroundPhysicians report difficulty convincing patients with prostate cancer about the merits of active surveillance (AS); as a result, a majority of patients unnecessarily choose to undergo radical treatment.

objectiveTo develop and evaluate a systematic approach for physicians to counsel patients with low-risk prostate cancer to increase acceptance of AS. DESIGN, SETTING, AND

participantsA systematic counseling approach was developed and piloted in one clinic. Then five surgeons participated in a 1-h training session in which they learned about the approach. A total of 1003 patients with Gleason 3+3 prostate cancer were included in the study. We compared AS rates for 761 patients who were counseled over a 24-mo period before the training intervention with AS rates for 242 patients who were counseled over a 12-mo period afterwards, controlling for temporal trends and case mix.

interventionA systematic approach for communicating the merits of AS using appropriate framing techniques derived from principles studied by negotiation scholars. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The rate of AS acceptance by patients for management of low-risk prostate cancer. RESULTS AND LIMITATIONS: In the pilot phase, 81 of 86 patients (94%) accepted AS after counseling by the physician who developed the counseling approach. In the subsequent study, the cohort for the training intervention comprised 1003 consecutive patients, 80% of whom met the Epstein criteria for very low-risk disease. The proportion of patients who selected AS increased from 69% before the training intervention to 81% afterwards. After adjusting for time trends and case mix, the rate of AS after the intervention was 9.1% higher (95% confidence interval -0.4% to 19.4%) than expected, a relative reduction of approximately 30% in the risk of unnecessary curative treatment.

conclusionsA systematic approach to counseling can be taught to physicians in a 1-h lecture. We found evidence that even this minimal intervention can decrease overtreatment. Our novel approach offers a framework to help address cancer screening-related overtreatment that occurs across medicine. PATIENT SUMMARY: In this study, we evaluated the impact of teaching physicians how to better communicate the benefits and risks of prostate cancer treatments on the willingness of patients to choose active surveillance. Decisions related to cancer are often guided by emotions and biases that lead most patients to seek radical treatment; however, we demonstrated that if discussions are framed differently, these biases can be overcome and more patients will choose active surveillance.

Indexed as

Education, MedicalInservice TrainingPersuasive CommunicationPhysician-Patient RelationsWatchful WaitingAgedAttitude of Health PersonnelCounselingEconomics, BehavioralHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPatient Acceptance of Health CarePatient Education as TopicProstatic NeoplasmsActive surveillanceBehavioral economicsCommunicationOutcomesProstate cancerSocial psychology

Identifiers

PMID28129893
PMCPMC5714298

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.